These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20072156)

  • 21. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC; Kraft AS
    Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts.
    Durual S; Rideau A; Ruault-Jungblut S; Cossali D; Beris P; Piguet V; Matthes T
    Leukemia; 2007 May; 21(5):1050-9. PubMed ID: 17361223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phorbol 12-myristate 13-acetate inhibits the antilipolytic action of insulin, probably via the activity of protein kinase Cε.
    Nakamura J
    Eur J Pharmacol; 2010 Dec; 648(1-3):188-94. PubMed ID: 20826143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactive oxygen species activate differentiation gene transcription of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway.
    Lam CF; Yeung HT; Lam YM; Ng RK
    Leuk Res; 2018 May; 68():112-119. PubMed ID: 29609096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch affects the prodifferentiating effect of retinoic acid and PMA on leukemic cells.
    Matulic M; Skelin J; Radic-Kristo D; Kardum-Skelin I; Grcevic D; Antica M
    Cytometry A; 2015 Feb; 87(2):129-36. PubMed ID: 25393162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of the oncogene PTTG1 via the KLF6 tumor suppressor during induction of myeloid differentiation.
    Chen PY; Yen JH; Kao RH; Chen JH
    PLoS One; 2013; 8(8):e71282. PubMed ID: 23977008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERK2-Pyruvate Kinase Axis Permits Phorbol 12-Myristate 13-Acetate-induced Megakaryocyte Differentiation in K562 Cells.
    Chaman N; Iqbal MA; Siddiqui FA; Gopinath P; Bamezai RN
    J Biol Chem; 2015 Sep; 290(39):23803-15. PubMed ID: 26269597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification.
    Park YS; Kang JW; Lee DH; Kim MS; Bak Y; Yang Y; Lee HG; Hong J; Yoon DY
    Oncotarget; 2014 Sep; 5(18):8765-77. PubMed ID: 25245533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLSCR1/IP3R1/Ca
    Li H; Xu J; Zhou Y; Liu X; Shen LE; Zhu YU; Li Z; Wang X; Guo Q; Hui H
    Cell Death Dis; 2017 May; 8(5):e2768. PubMed ID: 28492556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of β1,3-N-acetylglucosaminyltransferases during differentiation of human acute myeloid leukemia cells.
    Qiu H; Wu SL; Guo XH; Shen HJ; Zhang HP; Chen HL
    Mol Cell Biochem; 2011 Dec; 358(1-2):131-9. PubMed ID: 21720768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways related to PMA-differentiated THP1 human monocytic leukemia cells revealed by RNA-Seq.
    Zeng C; Wang W; Yu X; Yang L; Chen S; Li Y
    Sci China Life Sci; 2015 Dec; 58(12):1282-7. PubMed ID: 26582014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phospholipid scramblase 1.
    Huang Y; Zhao Q; Chen GQ
    Sheng Li Xue Bao; 2006 Dec; 58(6):501-10. PubMed ID: 17173184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The negative c-Myc target onzin affects proliferation and apoptosis via its obligate interaction with phospholipid scramblase 1.
    Li Y; Rogulski K; Zhou Q; Sims PJ; Prochownik EV
    Mol Cell Biol; 2006 May; 26(9):3401-13. PubMed ID: 16611984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terminal differentiation in vitro of patient-derived post-TMD megakaryoblastic AML cells.
    Classen CF; Gnekow A; Debatin KM
    Ann Hematol; 2003 Aug; 82(8):506-510. PubMed ID: 12910377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired host defense in mice lacking ONZIN.
    Ledford JG; Kovarova M; Koller BH
    J Immunol; 2007 Apr; 178(8):5132-43. PubMed ID: 17404296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PMA and doxorubicin decrease viability, MTT activity and expression of CD10 marker on NALM-1 leukemic cells.
    Martin-Kleiner I; Svoboda-Beusan I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 2006; 28(3):411-20. PubMed ID: 16997790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer.
    Li C; Ma H; Wang Y; Cao Z; Graves-Deal R; Powell AE; Starchenko A; Ayers GD; Washington MK; Kamath V; Desai K; Gerdes MJ; Solnica-Krezel L; Coffey RJ
    J Clin Invest; 2014 May; 124(5):2172-87. PubMed ID: 24691442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis suppression by candidate oncogene PLAC8 is reversed in other cell types.
    Mourtada-Maarabouni M; Watson D; Munir M; Farzaneh F; Williams GT
    Curr Cancer Drug Targets; 2013 Jan; 13(1):80-91. PubMed ID: 22920440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipid scramblase 1: a protein with multiple functions via multiple molecular interactors.
    Dal Col J; Lamberti MJ; Nigro A; Casolaro V; Fratta E; Steffan A; Montico B
    Cell Commun Signal; 2022 Jun; 20(1):78. PubMed ID: 35650588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifaced roles of PLAC8 in cancer.
    Mao M; Cheng Y; Yang J; Chen Y; Xu L; Zhang X; Li Z; Chen C; Ju S; Zhou J; Wang L
    Biomark Res; 2021 Oct; 9(1):73. PubMed ID: 34627411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.